Abstract
The prevalence of chronic kidney disease (CKD) continues to increase worldwide as does end stage renal disease. The most common, but not the only, causes of CKD are hypertension and diabetes. CKD is associated with a significant increase in cardiovascular (CV) risk as most patients with CKD die of a CV cause. Moreover, CV risk increases proportionally as eGFR falls below 60 mlmin−1. CV causes of death in CKD are more prevalent than those from cancer are; as a result, the identification and reduction of CKD is a public health priority. High blood pressure is a key pathogenic factor that contributes to the deterioration of kidney function. The presence of kidney disease is a common and underappreciated pre-existing medical cause of resistant hypertension. Therefore, treatment of hypertension has become the most important intervention in the management of all forms of CKD. For this reason, the forthcoming World Kidney Day on 12 March 2009 will emphasize the role of hypertension.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Sarafidis PA, Bakris GL . State of hypertension management in the United States: confluence of risk factors and the prevalence of resistant hypertension. J Clin Hypertens 2008; 10: 130–139.
Wen CP, Cheng TY, Tsai MK, Chang YC, Chan HT, Tsai SP et al. All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan. Lancet 2008; 371: 2173–2182.
McCullough PA, Jurkovitz CT, Pergola PE, McGill JB, Brown WW, Collins AJ et al. Independent components of chronic kidney disease as a cardiovascular risk state: results from the Kidney Early Evaluation Program (KEEP). Arch Intern Med 2007; 167: 1122–1129.
Atkins RC . The epidemiology of chronic kidney disease. Kidney Int Suppl 2005; 67: S14–S18.
Alebiosu CO, Ayodele OE . The global burden of chronic kidney disease and the way forward. Ethn Dis 2005; 15: 418–423.
Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N et al. Heart disease and stroke statistics—2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008; 117: e25–e146.
Ostchega Y, Yoon SS, Hughes J, Louis T . Hypertension Awareness, Treatment, and Control—Continued Disparities in Adults: United States, 2005–2006, NCHS Data Brief www.cdc.gov/nchs/data/databriefs/db03.pdf, 2008, pp 1–8.
Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P et al. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298: 2038–2047.
Sarafidis PA, Li S, Chen SC, Collins AJ, Brown WW, Klag MJ et al. Hypertension awareness, treatment, and control in chronic kidney disease. Am J Med 2008; 121: 332–340.
Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J . Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365: 217–223.
Peterson GE, de BT, Gabriel A, Ilic V, Vagaonescu T, Appel LJ et al. Prevalence and correlates of left ventricular hypertrophy in the African American Study of Kidney Disease Cohort Study. Hypertension 2007; 50: 1033–1039.
Townsend RR . Analyzing the radial pulse waveform: narrowing the gap between blood pressure and outcomes. Curr Opin Nephrol Hypertens 2007; 16: 261–266.
Perico N, Plata R, Anabaya A, Codreanu I, Schieppati A, Ruggenenti P et al. Strategies for national health care systems in emerging countries: the case of screening and prevention of renal disease progression in Bolivia. Kidney Int Suppl 2005; 68: S87–S94.
Whelton PK, Beevers DG, Sonkodi S . Strategies for improvement of awareness, treatment and control of hypertension: results of a panel discussion. J Hum Hypertens 2004; 18: 563–565.
Rao MV, Qiu Y, Wang C, Bakris G . Hypertension and CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES), 1999–2004. Am J Kidney Dis 2008; 51 (4 Suppl 2): S30–S37.
Acknowledgements
This editorial is being co-published in many journals during the month of March.
Author information
Authors and Affiliations
Consortia
Corresponding author
Rights and permissions
About this article
Cite this article
Bakris, G., Ritz, E. & on behalf of the World Kidney Day Steering Committee. The message for World Kidney Day 2009: hypertension and kidney disease— a marriage that should be prevented. J Hum Hypertens 23, 222–225 (2009). https://doi.org/10.1038/jhh.2008.169
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/jhh.2008.169
Keywords
This article is cited by
-
Uric acid level and kidney function: a cross-sectional study of the Korean national health and nutrition examination survey (2016–2017)
Scientific Reports (2020)
-
Effects of up-titration of candesartan versus candesartan plus amlodipine on kidney function in type 2 diabetic patients with albuminuria
Journal of Human Hypertension (2012)
-
Clinical correlates of renal dysfunction in hypertensive patients without cardiovascular complications: the REDHY study
Journal of Human Hypertension (2010)